Nemiga enters the NODWIN Clutch Series playoffs Bo3 with a modest ranking edge around the mid-50s on HLTV and a 2-0 head-to-head sweep over GenOne from January CCT play. The Belarusian side maintains roster stability with consistent map performers like KaiR0N- and khaN, while recent European results show solid win rates above 50 percent in tier-two events. GenOne, ranked near 67, has posted a strong late-July run with multiple 2-0 CCT victories yet mixed results in NODWIN qualifiers and occasional losses to similar-level opponents. Key variables include map selection favoring experienced lineups, current form momentum into the single-elimination bracket, and individual consistency under playoff pressure, as both squads compete in a competitive European field where small edges in execution often decide Bo3 outcomes.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedNemiga – GenOne




Series Lines
Moneyline
$1.4K Vol.
Map 2 Winner
$15 Vol.
Map Handicap
$0 Vol.
Total Maps
$0 Vol.
Map 1
Map 1 Total Rounds
$0 Vol.
Map 2
Map 2 Total Rounds
$0 Vol.
Map 3
Map 3 Total Rounds
$0 Vol.
This market will resolve to "Nemiga" if Nemiga win the match against GenOne.
This market will resolve to "GenOne" if GenOne win the match against Nemiga.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: Aug 2, 2026, 7:14 AM ET
Resolution Source
https://hltv.orgResolver
0x65070BE91...Nemiga – GenOne




Series Lines
Moneyline
$1.4K Vol.
Map 2 Winner
$15 Vol.
Map Handicap
$0 Vol.
Total Maps
$0 Vol.
Map 1
Map 1 Total Rounds
$0 Vol.
Map 2
Map 2 Total Rounds
$0 Vol.
Map 3
Map 3 Total Rounds
$0 Vol.
This market will resolve to "Nemiga" if Nemiga win the match against GenOne.
This market will resolve to "GenOne" if GenOne win the match against Nemiga.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Market Opened: Aug 2, 2026, 7:14 AM ET
Resolution Source
https://hltv.orgResolver
0x65070BE91...Nemiga enters the NODWIN Clutch Series playoffs Bo3 with a modest ranking edge around the mid-50s on HLTV and a 2-0 head-to-head sweep over GenOne from January CCT play. The Belarusian side maintains roster stability with consistent map performers like KaiR0N- and khaN, while recent European results show solid win rates above 50 percent in tier-two events. GenOne, ranked near 67, has posted a strong late-July run with multiple 2-0 CCT victories yet mixed results in NODWIN qualifiers and occasional losses to similar-level opponents. Key variables include map selection favoring experienced lineups, current form momentum into the single-elimination bracket, and individual consistency under playoff pressure, as both squads compete in a competitive European field where small edges in execution often decide Bo3 outcomes.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.
Frequently Asked Questions
Build a combo
Select two options
Beware of external links.
Beware of external links.
Frequently Asked Questions